ethosuximide has been researched along with Systemic Vasculitis in 1 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Systemic Vasculitis: A heterogeneous group of diseases characterized by inflammation and necrosis of the blood vessel walls.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ethosuximide was halted and due to the severe symptoms, treatment with both prednisolone and intravenous iloprost was commenced." | 5.72 | Severe Raynaud's phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report. ( Berntson, L; Liminga, G, 2022) |
| "Ethosuximide was halted and due to the severe symptoms, treatment with both prednisolone and intravenous iloprost was commenced." | 1.72 | Severe Raynaud's phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report. ( Berntson, L; Liminga, G, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berntson, L | 1 |
| Liminga, G | 1 |
1 other study available for ethosuximide and Systemic Vasculitis
| Article | Year |
|---|---|
Severe Raynaud's phenomenon from ethosuximide raised concern over possible onset of systemic vasculitis: a case report.
Topics: Child; Connective Tissue Diseases; Ethosuximide; Female; Fingers; Humans; Pain; Raynaud Disease; Sys | 2022 |